Hongbo Wei

Prof. Hongbo Wei


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2021 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
JSJun Shao
Jun Shao
RLRongpu Liang
Rongpu Liang
DDDongbing Ding
Dongbing Ding
XZXiaoming Zheng
Xiaoming Zheng
XZXudong Zhu
Xudong Zhu
BWBo Wei
Bo Wei
Background: Surgery is considered to be a potentially curative approach for gastric cancer. However, most cases are diagnosed at a very advanced stage for the lack of typical symptoms in the initial stage, which makes it difficult to completely surgical resect of tumors. Early diagnosis and precise personalized intervention are urgent issues to be solved for improving the prognosis of gastric cancer. Herein, we developed an RGD-modified ROS-responsive multifunctional nanosystem for near-infrared (NIR) imaging and photothermal therapy (PTT) against gastric cancer. Methods: Firstly, the amphiphilic polymer was synthesized by bromination reaction and nucleophilic substitution reaction of carboxymethyl chitosan (CMCh) and 4-hydroxymethyl-pinacol phenylborate (BAPE). Then, it was used to encapsulate indocyanine green (ICG) and modified with RGD to form a smart multifunctional nanoparticle targeted to gastric cancer ([email protected]). The characteristics were determined, and the targeting capacity and biosafety were evaluated both in vitro and in vivo. Furthermore, [email protected] mediated photothermal therapy (PTT) effect was studied using gastric cancer cells (SGC7901) and SGC7901 tumor model. Results: The nanoparticle exhibited suitable size (≈ 120 nm), improved aqueous stability, ROS-responsive drug release, excellent photothermal conversion efficiency, enhanced cellular uptake, and targeting capacity to tumors. Remarkably, in vivo studies suggested that [email protected] could accurately illustrate the location and margin of the SGC7901 tumor through NIR imaging in comparison with non-targeted nanoparticles. Moreover, the antitumor activity of [email protected] PTT could effectively suppress tumor growth by inducing necrosis and apoptosis in cancer cells. Additionally, [email protected] demonstrated excellent biosafety both in vitro and in vivo. Conclusion: Overall, our study provides a biocompatible theranostic nanoparticle with enhanced tumor-targeting ability and accumulation to realize NIR image-guided PTT in gastric cancer.

5 October 2020 in Biomaterials
Verified
Journal Article
Closed access
CLChenghua Liang
Chenghua Liang
XBXiangyang Bai
Xiangyang Bai
CQCuiling Qi
Cuiling Qi
QSQingxue Sun
Qingxue Sun
XHXiaoyan Han
Xiaoyan Han
BWBo Wei
Bo Wei

20 February 2025 in Journal of Clinical Oncology
Verified
Journal Article
Closed access
JZJianwei Zhang
Jianwei Zhang
CPChi Pan
Chi Pan
LSLishuo Shi
Lishuo Shi
LCLong Cui
Long Cui
JGJinbo Gao
Jinbo Gao
YDYanghong Deng
Yanghong Deng
We present 10-year results of the phase Ⅲ FOWARC trial, which evaluated the efficacy of modified infusional fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6) with or without radiation compared with fluorouracil with radiation in patients with locally advanced rectal cancer. A total of 495 patients age 18-75 years with stage Ⅱ-Ⅲ rectal cancer were randomly assigned to three treatment arms: fluorouracil plus radiotherapy, mFOLFOX6 plus radiotherapy, or mFOLFOX6 alone, followed by surgery and adjuvant chemotherapy. With a median follow-up of 10 years, the 10-year disease-free survival (DFS) rates were 52.5%, 62.6%, and 60.5%, respectively ( P = .56). The 10-year locoregional recurrence (LR) rates were 10.8%, 8.0%, and 9.6% ( P = .57), and the 10-year overall survival (OS) rates were 65.9%, 72.3%, and 73.4% ( P = .90). Subgroup analysis identified ypTNM stage as a significant prognostic factor for DFS, LR, and OS ( P < .0001, P < .006, P < .0001, respectively). Patients achieving pathologic complete response had 10-year DFS, LR, and OS rates of 84.3%, 3.0%, and 92.4%, respectively. No significant difference was observed in long-term survival outcome between mFOLFOX6 with and without radiation and fluorouracil plus radiation. These results demonstrate that neoadjuvant mFOLFOX6 chemotherapy can be considered as a therapeutic option in LARC.

1 March 2019 in Human Pathology
Verified
Journal Article
Closed access
LGLi-Ping Gong
Li-Ping Gong
JCJian-Ning Chen
Jian-Ning Chen
LXLin Xiao
Lin Xiao
QHQiong He
Qiong He
ZFZhi-Ying Feng
Zhi-Ying Feng
CSChun-kui Shao
Chun-kui Shao

31 May 2022 in Bioengineering & Translational Medicine
Verified
Journal Article
Open access
JSJun Shao
Jun Shao
PNPan Nie
Pan Nie
WYWende Yang
Wende Yang
RGRui Guo
Rui Guo
DDDongbing Ding
Dongbing Ding
HWHongbo Wei
Hongbo Wei
Neurogenic erectile dysfunction (nED) is one of the most common and intractable postoperative complications of rectal and prostate cancer surgery and sometimes accompanies patients lifelong. The transplantation of stem cells has been proved a promising way for treatment. However, the therapeutic efficacy is severely impaired by excessive cell loss and death and poor accumulation in the injury site along with the traditional implantation strategy. Herein, an EPO‐loaded multifunctional hydrogel was designed. The hydrogels' adhesive property and mechanical strength were enhanced by adding catechol‐catechol adducts, thus significantly improving adipose‐derived stem cells (ADSC) retention and rescuing cell loss in the injury site. Meanwhile, the sustained release of EPO effectively ameliorated the viability and paracrine activity of ADSC, leading to enhanced migration of Schwann cells and differentiation of PC12 cells in vivo. On a bilateral cavernous nerve injury rat model, the present stem cell‐EPO‐hydrogel implanted strategy could significantly alleviate erectile dysfunction. The higher expression of Tuj1 and lower expression of GFAP in the major pelvic ganglia (MPG) indicated the acceleration of neural differentiation while the suppressing development of astrocytes. Also, the combined therapy restored the expression levels of eNOs, nNOs, and α‐SMA in penile tissues, suggesting the rehabilitation of the penis. Further analysis of Masson trichrome staining and apoptosis evaluation of the corpus cavernosum showed the preservation of vascular endothelium content and the prevention of penile fibrosis after denervation. Overall, we believe that this combined strategy presents a promising way not only for restoring neurogenic erectile function but also for the clinical translation of stem cell therapy.

13 January 2020 in Cell Proliferation
Verified
Journal Article
Open access
PDF file
WYWende Yang
Wende Yang
ZCZehong Chen
Zehong Chen
XMXiaolei Ma
Xiaolei Ma
XOXi Ouyang
Xi Ouyang
JFJiafeng Fang
Jiafeng Fang
HWHongbo Wei
Hongbo Wei
Objectives: To evaluate the rapid repair potential of adipose‐derived stem cells (ADSCs) co‐overexpressing VEGF and GDNF on bilateral cavernous nerve injury (BCNI) in rat models. Progressive fibrosis of the penis that occurs shortly after BCNI is a key cause of clinical treatment difficulty of erectile dysfunction (ED). Traditional medications are ineffective for ED caused by BCNI. ADSCs have shown therapeutic effects in animal models, but disappointing in clinical treatment suggests that we should explore optimal treatment of it.Materials and methods: We extracted ADSCs from rat epididymis. Lentiviral transfection was verified by western blot and immunofluorescence. Thirty‐six SD rats (10 weeks old) were randomly divided into six groups (n = 6 per group): sham surgery, and remaining five BCNI groups transplanted PBS or ADSCs which were genetically modified by vehicle, VEGF (ADSC‐V), GDNF (ADSC‐G), or VEGF&GDNF (ADSC‐G&V) around major pelvic ganglion (MPG). We investigated the therapeutic effects of BCNI rat model which is characterized by ED, penile tissue fibrosis and hypoxia, and lack of nitrogen nerves or vascular atrophy.Results: Erectile function was almost recovered after 2 weeks of transplantation of ADSC‐G&V, promoted cavernous nerve repair, prevented penile fibrosis and preserving the vascular endothelium, which was significant differences amongst ADSC‐V or ADSC‐G. Moreover, GM‐ADSCs were detected in MPG and penis, indicating that their participation in repair of target organs and transverse nerves.Conclusions: These promising data indicate that ADSCs co‐overexpressed VEGF and GDNF‐induced synergistic effects, make it a potential tool for recovering of erectile function speedily after BCNI.